One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 230,000 shares of Pfizer Inc. (NYSE: PFE) on Tuesday, as the price of this fund pulled back over 2% in the day’s session. However, it is up a fair amount in the past year.
[in-text-ad]
ARK Genomic Revolution ETF (NYSEARCA: ARKG) parted with 238,235 shares of Pfizer. At Tuesday’s closing price, this would have valued this sale at roughly $11.3 million. This is only a small fraction of the total holdings. The fund is up about 10% over the past 52 weeks.
Check out all the ARK Invest buys for Tuesday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKG | REGN | REGENERON PHARMACEUTICALS | 17,447 |
| ARKG | PFE | PFIZER | 238,235 |
| ARKG | CSTL | CASTLE BIOSCIENCES | 200 |
| ARKG | CLLS | CELLECTIS | 25,000 |
| ARKK | PRLB | PROTO LABS | 23,707 |
| ARKK | U | UNITY SOFTWARE | 121,968 |
| ARKQ | U | UNITY SOFTWARE | 47,465 |
| ARKW | RBLX | ROBLOX | 82,267 |
| ARKW | U | UNITY SOFTWARE | 33,281 |
| ARKX | U | UNITY SOFTWARE | 5,343 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.
24/7 Wall St.Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Get started right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
